Synopsis: This white paper discusses the value of cardio-oncology programs, examines common barriers in cardio-oncology care, and provides strategies for how hospital and health system leaders can advance cardio-oncology care. It also includes insights from a recent group discussion Q-Centrix held with cardio-oncology program leaders from partner hospitals and health systems.
Cardio-oncology is emerging as a critical frontier in cancer care. With cancer treatments increasing patients’ risk of cardiovascular disease, the need for a coordinated approach to cardio-oncology care is paramount.
Our newest white paper features insights from cardio-oncology program leaders at partner hospitals and health systems and discusses the value of cardio-oncology programs. With expert insights and strategies for building and growing these programs, this white paper will help you uncover solutions for advancing cardio-oncology care at your facility.
This White Paper Is For:
- Hospital and health system leaders interested in understanding the benefits of cardio-oncology programs
- Cardiovascular and oncology leaders who want to develop or expand a cardio-oncology program at their facility
- Those interested in hearing insights from cardio-oncology program leaders at Q-Centrix partner hospitals and health systems
- Cardiovascular and oncology leaders looking for strategies to better support cancer patients at risk of cardiovascular disease
